The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): Recent Progress in the Evaluation of Alternative Toxicity Testing Methods

Over the last decade, national authorities in the USA and Europe have launched initiatives to validate new and improved toxicological test methods. In the USA, the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), and its supporting National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), were established by the Federal Government to work with test developers and Federal agencies to facilitate the validation, review, and adoption of new scientifically sound test methods, including alternatives that can reduce, refine, and replace animal use. In Europe, the European Centre for the Validation of Alternative Methods (ECVAM) was established to conduct validation studies on alternative test methods. Despite differences in organisational structure and processes, both organisations seek to achieve the adoption and use of alternative test methods. Accordingly, both have adopted similar validation and regulatory acceptance criteria. Collaborations and processes have also evolved to facilitate the international adoption of new test methods recommended by ECVAM and ICCVAM. These collaborations involve the sharing of expertise and data for test-method workshops and independent scientific peer reviews, and the adoption of processes to expedite the consideration of test methods already reviewed by the other organisation. More recently, NICEATM and ECVAM initiated a joint international validation study on in vitro methods for assessing acute systemic toxicity. These collaborations are expected to contribute to accelerated international adoption of harmonised new test methods that will support improved public health and provide for reduced and more-humane use of laboratory animals.

[1]  W S Stokes,et al.  ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. , 2001, Regulatory toxicology and pharmacology : RTP.

[2]  M. Wagoner Chemical injuries of the eye: current concepts in pathophysiology and therapy. , 1997, Survey of ophthalmology.

[3]  W. Halle Toxizitätsprüfungen in Zellkulturen für eine Vorhersage der akuten Toxizität (LD50) zur Einsparung von Tierversuchen , 1998 .

[4]  Horst Spielmann,et al.  Determination of the Starting dose for Acute Oral Toxicity (LD50) Testing in the up and down Procedure (UDP) from Cytotoxicity Data , 1999, Alternatives to laboratory animals : ATLA.

[5]  B. Isomaa,et al.  MEIC Evaluation of Acute Systemic Toxicity: Part VI. The Prediction of Human Toxicity by Rodent LD50 Values and Results From 61 In Vitro Methods. , 1998, Alternatives to laboratory animals : ATLA.

[6]  W S Stokes,et al.  Validation and Regulatory Acceptance of Alternatives , 1999, Cambridge Quarterly of Healthcare Ethics.

[7]  J. Ashby,et al.  Lack of binding to isolated estrogen or androgen receptors, and inactivity in the immature rat uterotrophic assay, of the ultraviolet sunscreen filters Tinosorb M-active and Tinosorb S. , 2001, Regulatory toxicology and pharmacology : RTP.

[8]  C. C. Lee,et al.  Use of ophthalmic topical anaesthetics. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  Michael Balls,et al.  Statement on the application of the CORROSITEX assay for skin corrosivity testing. , 2001, Alternatives to laboratory animals : ATLA.

[10]  W S Stokes,et al.  Introduction and summary of the 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies. , 1998, Environmental health perspectives.

[11]  Stokes Ws,et al.  Guidelines for Institutional Animal Care and Use Committees: consideration of alternatives. , 1995 .

[12]  W S Stokes,et al.  ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process. , 2001, Regulatory toxicology and pharmacology : RTP.

[13]  J. A. Bradlaw,et al.  Workshop on eye irritation testing: practical applications of non-whole animal alternatives , 1997 .

[14]  W. Stokes,et al.  ECVAM-ICCVAM: Prospects for Future Collaboration , 2002, Alternatives to laboratory animals : ATLA.

[15]  A M Goldberg,et al.  The Three Rs: The Way Forward , 1995, Alternatives to laboratory animals : ATLA.

[16]  A P Worth,et al.  The Role of ECVAM in Promoting the Regulatory Acceptance of Alternative Methods in the European Union , 2001, Alternatives to laboratory animals : ATLA.

[17]  I. Purchase,et al.  Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Michael Balls,et al.  The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11. , 1995, Alternatives to laboratory animals : ATLA.

[19]  B H Margolin,et al.  ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. , 2001, Regulatory toxicology and pharmacology : RTP.